We hope that our findings elucidate the molecular mechanism of Sirt3 modulators in regulating insulin signaling pathway and highlight the therapeutic potential of Sirt3 activator in the treatment of type 2 diabetes and metabolic diseases. The gene discussed is INS; the disease is type 2 diabetes mellitus.